9,145€
0,33%
Echtzeit-Aktienkurs CLINUVEL PHARMACEUTICALS
Bid:
Ask:
Echtzeit-Chart der CLINUVEL PHARMACEUTICALS Aktie
Börsenkurse CLINUVEL PHARMACEUTICALS
| Börse Stuttgart | - | - | - | - | 9,040€ | -0,17% |
| Echtzeit Euro | - | - | - | - | 8,978€ | -1,99% |
| gettex | - | - | - | - | 9,145€ | 0,22% |
| Lang & Schwarz | - | - | - | - | 9,075€ | -0,27% |
| Tradegate | - | - | - | - | 9,145€ | 0,33% |
| Börse Frankfurt | - | - | - | - | 9,103€ | 0,58% |
Profil der CLINUVEL PHARMACEUTICALS Aktie
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.